Niels van Royen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Niels van Royen has a total of 283 co-authors. Here are the top co-authors by number of shared publications:
- Paul Knaapen
Department of Cardiology, Heart Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands
14 shared publications Maurits R. Hollander
10 shared publications- Paul F. A. Teunissen
Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands
8 shared publications Guus de Waard
7 shared publications- Javier Escaned
Department of Cardiology, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (IdlSSC), Hospital Clinico San Carlos, Universidad Complutense, 28040 Madrid, Spain
7 shared publications - Ibrahim Danad
Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands
6 shared publications
Latest Publications
- Open Access
- 22 September 2017
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 6 (9) , e006082
Body Mass Index Is Associated With Microvascular Endothelial Dysfunction in Patients With Treated Metabolic Risk Factors and Suspected Coronary Artery Disease
Background: Obesity is key feature of the metabolic syndrome and is associated with high cardiovascular morbidity and mortality. Obesity is associated with macrovascular endothelial dysfunction, a determinant of outcome in patients with coronary artery disease. Here, we compared the influence of obesity on microvascular endothelial function to that of established cardiovascular risk factors such as diabetes mellitus, hypertension, hypercholesterolemia, and smoking in patients with suspected coronary artery disease. Methods and Results: Endothelial function was assessed during postocclusive reactive hyperemia of the brachial artery and downstream microvascular beds in 108 patients who were scheduled for coronary angiography. In all patients, microvascular vasodilation was assessed using peripheral arterial tonometry; laser Doppler flowmetry and digital thermal monitoring were performed. Body mass index was significantly associated with decreased endothelium‐dependent vasodilatation measured with peripheral arterial tonometry ( r =0.23, P =0.02), laser Doppler flowmetry ( r =0.30, P r =0.30, P P =0.19, laser Doppler flowmetry: 728% [interquartile range, 427–1110] versus 589% [interquartile range, 320–1067] P =0.28, and digital thermal monitoring: 6.6±1.0% versus 2.5±1.7%, P =0.08). In multivariate linear regression analysis, body mass index was the only risk factor that significantly attenuated endothelium‐dependent vasodilatation using all 3 microvascular function tests. Conclusions: Higher body mass index is associated with reduced endothelial function in patients with suspected coronary artery disease, even after adjustment for treated diabetes mellitus, hypertension, hypercholesterolemia, and smoking.
- 22 September 2017
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 6 (9) , e006082
Open AccessBody Mass Index Is Associated With Microvascular Endothelial Dysfunction in Patients With Treated Metabolic Risk Factors and Suspected Coronary Artery Disease
Background: Obesity is key feature of the metabolic syndrome and is associated with high cardiovascular morbidity and mortality. Obesity is associated with macrovascular endothelial dysfunction, a determinant of outcome in patients with coronary artery disease. Here, we compared the influence of obesity on microvascular endothelial function to that of established cardiovascular risk factors such as diabetes mellitus, hypertension, hypercholesterolemia, and smoking in patients with suspected coronary artery disease. Methods and Results: Endothelial function was assessed during postocclusive reactive hyperemia of the brachial artery and downstream microvascular beds in 108 patients who were scheduled for coronary angiography. In all patients, microvascular vasodilation was assessed using peripheral arterial tonometry; laser Doppler flowmetry and digital thermal monitoring were performed. Body mass index was significantly associated with decreased endothelium‐dependent vasodilatation measured with peripheral arterial tonometry ( r =0.23, P =0.02), laser Doppler flowmetry ( r =0.30, P r =0.30, P P =0.19, laser Doppler flowmetry: 728% [interquartile range, 427–1110] versus 589% [interquartile range, 320–1067] P =0.28, and digital thermal monitoring: 6.6±1.0% versus 2.5±1.7%, P =0.08). In multivariate linear regression analysis, body mass index was the only risk factor that significantly attenuated endothelium‐dependent vasodilatation using all 3 microvascular function tests. Conclusions: Higher body mass index is associated with reduced endothelial function in patients with suspected coronary artery disease, even after adjustment for treated diabetes mellitus, hypertension, hypercholesterolemia, and smoking.
- 1 May 2017
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 10 (5)
Early Detection and Treatment of the Vulnerable Coronary Plaque
Early identification and treatment of the vulnerable plaque, that is, a coronary artery lesion with a high likelihood of rupture leading to an acute coronary syndrome, have gained great interest in the cardiovascular research field. Postmortem studies have identified clear morphological characteristics associated with plaque rupture. Recent advances in invasive and noninvasive coronary imaging techniques have empowered the clinician to identify suspected vulnerable plaques in vivo and paved the way for the evaluation of therapeutic agents targeted at reducing plaque vulnerability. Local treatment of vulnerable plaques by percutaneous coronary intervention and systemic treatment with anti-inflammatory and low-density lipoprotein–lowering drugs are currently being investigated in large randomized clinical trials to assess their therapeutic potential for reducing adverse coronary events. Results from these studies may enable a more patient-tailored strategy for the treatment of coronary artery disease.
- 1 May 2017
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 10 (5)
Early Detection and Treatment of the Vulnerable Coronary Plaque
Early identification and treatment of the vulnerable plaque, that is, a coronary artery lesion with a high likelihood of rupture leading to an acute coronary syndrome, have gained great interest in the cardiovascular research field. Postmortem studies have identified clear morphological characteristics associated with plaque rupture. Recent advances in invasive and noninvasive coronary imaging techniques have empowered the clinician to identify suspected vulnerable plaques in vivo and paved the way for the evaluation of therapeutic agents targeted at reducing plaque vulnerability. Local treatment of vulnerable plaques by percutaneous coronary intervention and systemic treatment with anti-inflammatory and low-density lipoprotein–lowering drugs are currently being investigated in large randomized clinical trials to assess their therapeutic potential for reducing adverse coronary events. Results from these studies may enable a more patient-tailored strategy for the treatment of coronary artery disease.
- Open Access
- 6 March 2017
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 25 (4) , 229-230
Statins; the panacea of cardiovascular disease
- 6 March 2017
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 25 (4) , 229-230
Open AccessStatins; the panacea of cardiovascular disease
- 1 February 2017
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 12 (14) , 1773-1781
Non-invasive assessment of the collateral circulation in the hand: validation of the Nexfin system and relation to clinical outcome after transradial catheterisation
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 February 2017
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 12 (14) , 1773-1781
Non-invasive assessment of the collateral circulation in the hand: validation of the Nexfin system and relation to clinical outcome after transradial catheterisation
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)